Results 81 to 90 of about 22,957 (260)

Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism

open access: yesRenal Failure, 2020
Background Hungry bone syndrome (HBS) following parathyroidectomy is associated with severe hypocalcemia and increased morbidity. This study aims to determine the incidence and risk factors of post-parathyroidectomy HBS in dialysis patients with ...
Kittrawee Kritmetapak   +5 more
doaj   +1 more source

Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease [PDF]

open access: yes, 2016
Secondary hyperparathyroidism (SHPT) is a common complication of CKD and is part of the chronic kidney disease-mineral bone disorder (CKD-MBD). SHPT is associated with increased risk of fracture and mortality, thus SHPT control is recommended as kidney ...
Khwaja, A., Salam, S.N., Wilkie, M.E.
core   +1 more source

Chondrocalcinosis after parathyroidectomy. [PDF]

open access: yesAnnals of the Rheumatic Diseases, 1976
In this retrospective study of 57 patients with primary hyperparathyroidism who underwent parathyroidectomy, the overall incidence of chondrocalcinosis was 40%. Neither joint symptoms nor chondrocalcinosis regressed after the operation. In several patients the condition appeared to deteriorate both clinically and radiologically after the operation ...
J S Glass, R Grahame
openaire   +3 more sources

Outcome of surgical parathyroidectomy for tertiary hyperparathyroidism in kidney transplant recipients: tertiary hyperparathyroidism should not be ignored, for the sake of precious allografts

open access: yesRenal Failure
Tertiary hyperparathyroidism is a complication of kidney transplantation. This complicated condition carries over from the dialysis period and varies according to the function of the transplanted allograft.
Michio Nakamura   +3 more
doaj   +1 more source

Primary Hyperparathyroidism in Pregnancy: Successful Parathyroidectomy during First Trimester

open access: yesCase Reports in Endocrinology, 2018
Primary hyperparathyroidism in pregnancy can result in significant maternal and fetal complications. When indicated, prompt parathyroidectomy in the early second trimester is considered the treatment of choice.
Niranjan Tachamo   +5 more
doaj   +1 more source

Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation [PDF]

open access: yes, 2018
Background and aims: Intra-operative parathyroid hormone (IOPTH) results are not known in the setting of tertiary hyperparathyroidism (HPT) after renal transplantation.
Dosseh, David   +7 more
core  

Stellenwert der minimal-invasiven Chirurgie beim primären und sekundären Hyperparathyroidismus [PDF]

open access: yes, 2009
BACKGROUND: The standard surgical approach to treat primary (pHPT) and secondary hyperparathyroidism (sHPT) used to be a cervicotomy with exploration of all four parathyroid glands.
Bortoluzzi, L   +3 more
core   +1 more source

Factors Increasing the Likelihood of Postoperative Hematomas Following Thyroid Surgery

open access: yesHead &Neck, Volume 47, Issue 7, Page 1897-1906, July 2025.
ABSTRACT Background Neck hematoma following thyroid surgery is a potentially life‐threatening complication. Methods This retrospective case–control study reviewed neck hematoma reoperations following thyroid surgery (2009–2024), using 3:1 matching. Univariable analysis identified hematoma and delayed onset (≥ 6 h) risk factors, with odds ratios (ORs ...
Emily Ajit‐Roger   +9 more
wiley   +1 more source

Parathyroidectomy in the calcimimetic era [PDF]

open access: yesNephrology, 2005
SUMMARY:  With the introduction of the calcimimetic cinacalcet HCl, some patients who would previously have undergone parathyroidectomy are likely to remain on medical therapy. Data is available on complication rates and some important outcome measures of parathyroidectomy, but the efficacy of calcimimetics to influence patient‐based endpoints such as ...
openaire   +3 more sources

A Case of Advanced Renal Cell Carcinoma With Concomitant Development of Multiple Endocrine Neoplasia Type 1 That Affected Treatment Progress With Immunotherapy

open access: yesIJU Case Reports, Volume 8, Issue 4, Page 338-342, July 2025.
ABSTRACT Introduction Hypercalcemia is a poor prognostic factor in advanced cancer. Case Presentation A patient with advanced clear cell renal carcinoma with hypercalcemia was treated with nivolumab+ipilimumab combination therapy. Treatment was discontinued after 4 months due to renal dysfunction.
Masataka Abe   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy